GENEBIOTECH

The current price of 086060 is 3930 KRW — it has increased by 0.90% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENEBIOTECH stocks are traded under the ticker 086060.

086060 stock is 1.55% volatile and has beta coefficient of 0.13. Check out the list of the most volatile stocks — is GENEBIOTECH there?

Yes, you can track GENEBIOTECH financials in yearly and quarterly reports right on TradingView.

086060 stock has fallen by 0.76% compared to the previous week, the month change is a 3.91% fall, over the last year GENEBIOTECH has showed a 9.97% decrease.

086060 net income for the last quarter is ‪407.47 M‬ KRW, while the quarter before that showed ‪777.87 M‬ KRW of net income which accounts for −47.62% change. Track more GENEBIOTECH financial stats to get the full picture.

GENEBIOTECH dividend yield was 0% in 2023, and payout ratio reached 0%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.

Like other stocks, 086060 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENEBIOTECH stock right from TradingView charts — choose your broker and connect to your account.

086060 reached its all-time high on Jun 8, 2016 with the price of 11100 KRW, and its all-time low was 1070 KRW and was reached on Oct 29, 2008.
See other stocks reaching their highest and lowest prices.

As of Apr 18, 2024, the company has 41.00 employees. See our rating of the largest employees — is GENEBIOTECH on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENEBIOTECH technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENEBIOTECH stock shows the strong sell signal. See more of GENEBIOTECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENEBIOTECH EBITDA is ‪4.98 B‬ KRW, and current EBITDA margin is 6.27%. See more stats in GENEBIOTECH financial statements.